Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments
Completed enrollment in Phase 2b RELIEF trial of Licaminlimab , anti-TNF alpha eye drops in Dry Eye Disease ; topline results expected in Q2 2024Second Phase 3 trial of OCS-01 eye drops in Diabetic...